
|Articles|April 5, 2004
Medicare Rx benefit threatens independent pharmacy
The Medicare Rx drug benefit could slash independent pharmacies' gross margins by 8%, sending them over the edge of unprofitability, according to industry analyst Arthur Flynn.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Hormone Replacement Therapy May Lower Dementia Risk in Postmenopausal Women
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
Explaining COVID-19 Vaccine Side Effects to Anxious Patients
5







































